Acceleron Pharma
XLRN
#1587
Rank
ยฃ8.43 B
Marketcap
ยฃ137.85
Share price
0.00%
Change (1 day)
14,259.56%
Change (1 year)

Revenue for Acceleron Pharma (XLRN)

Revenue in 2021 (TTM): ยฃ82.64 Million

According to Acceleron Pharma's latest financial reports the company's current revenue is ยฃ86.96 Million. In 2020 the company made a revenue of ยฃ71.35 Million an increase over the revenue in the year 2019 that were of ยฃ57.06 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Acceleron Pharma from 2012 to 2021

Annual revenue

Year Revenue Change
2021 (TTM)ยฃ82.64 M15.82%
2020ยฃ71.35 M25.05%
2019ยฃ57.06 M428.85%
2018ยฃ10.78 M3.78%
2017ยฃ10.39 M-51.45%
2016ยฃ21.41 M53.47%
2015ยฃ13.95 M23.68%
2014ยฃ11.28 M-74.43%
2013ยฃ44.13 M275.17%
2012ยฃ11.76 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
ยฃ25.08 B 28,751.41%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ10.67 B 12,179.72%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ67.63 B 77,669.50%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ0.17 M-99.80%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ9.46 M-89.11%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ42.33 M-51.31%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ42.91 B 49,243.76%๐Ÿ‡บ๐Ÿ‡ธ USA